Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy with poxvirus vectors.

Dorota Moroziewicz1, Howard L Kaufman

  • 1Columbia University, Department of Surgery, 177 Fort Washington Avenue, MHB-7SK, New York, NY 10032, USA.

Current Opinion in Molecular Therapeutics
|August 27, 2005
PubMed
Summary

Recombinant poxviruses, like vaccinia virus, are versatile DNA vectors for gene therapy. Their ability to elicit strong immune responses and be engineered for transient expression aids in developing vaccines and treating diseases like HIV and cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local immunotherapy for the treatment of cancer: scientific advances and clinical potential.

Journal for immunotherapy of cancer·2026
Same author

Temporal molecular remodeling of T cells informs their possible adaptation in 4T1 tumors.

Computational and structural biotechnology journal·2026
Same author

Generation of a male isogenic pair and a female isogenic pair(R83C) for studying NAA10-related syndrome as part of a large Ogden syndrome biobank.

Stem cell research·2026
Same author

Targeting Tumor-Draining Lymph Nodes to Improve the Therapeutic Potential of Oncolytic Viruses.

Cancer immunology research·2026
Same author

Locally Advanced Conjunctival Squamous Cell Carcinoma not Responsive to Immune Checkpoint Inhibitor Therapy: 3 Cases and a Literature Review.

Ophthalmic plastic and reconstructive surgery·2026
Same author

Letter to the EditorTumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy.

Neuro-oncology·2025

Area of Science:

  • Virology
  • Immunology
  • Gene Therapy

Background:

  • Poxviruses are DNA viruses capable of expressing foreign genes.
  • Understanding viral immune regulation has led to engineered poxvirus vectors.
  • Recombinant vaccinia virus is a key example, inducing potent immune responses.

Purpose of the Study:

  • To review the current applications of recombinant poxviruses in gene therapy.
  • To highlight advancements in manipulating immune responses to poxvirus vectors.
  • To discuss the potential of poxviruses as vectors for human disease treatment.

Main Methods:

  • Review of scientific literature on recombinant poxviruses.
  • Analysis of poxvirus vector design for immune modulation.
  • Examination of poxvirus applications in vaccine development and gene therapy.

Main Results:

  • Poxviruses are effective vectors for expressing foreign genes.
  • Engineered poxviruses can be designed for specific immune induction levels.
  • Non-replicating poxviruses offer options for transient gene expression.
  • Molecular mediators of immunity can be used to enhance poxvirus vector efficacy.

Conclusions:

  • Recombinant poxviruses are valuable tools for gene therapy.
  • Further research into immune mediators can optimize poxvirus vector strategies.
  • Poxviruses hold significant promise for treating human diseases like HIV and cancer.

Related Experiment Videos